By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Theophylline

Theophylline

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|678 words

Theophylline Drug Profile

What is Theophylline?

Theophylline is a bronchodilator medication that belongs to the methylxanthine class of drugs. It is primarily used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) by helping to open the airways and improve breathing. This medication works by relaxing the smooth muscles in the bronchial tubes and reducing inflammation in the respiratory tract.

Uses

Theophylline is prescribed for several respiratory conditions:

Asthma management: Used as a long-term controller medication to prevent asthma symptoms and reduce the frequency of attacks, particularly for patients whose symptoms are not well-controlled with other medications.

Chronic obstructive pulmonary disease (COPD): Helps manage symptoms of COPD including chronic bronchitis and emphysema by improving airflow and reducing breathing difficulties.

Submit Your Paper
GMJ_Submit_Banner

Apnea of prematurity: Used in premature infants to stimulate breathing and reduce episodes of apnea (temporary cessation of breathing).

Chronic bronchitis: Provides bronchodilation and may help reduce inflammation in patients with chronic bronchitis who experience persistent airway obstruction.

Exercise-induced bronchospasm: Sometimes prescribed to prevent breathing difficulties triggered by physical activity in susceptible individuals.

How it works

Theophylline works through multiple mechanisms to improve breathing. It inhibits an enzyme called phosphodiesterase, which leads to increased levels of cyclic adenosine monophosphate (cAMP) in cells, resulting in relaxation of bronchial smooth muscle and dilation of the airways. Additionally, theophylline has anti-inflammatory properties and may strengthen the contractions of the diaphragm muscle, further improving respiratory function.

Side effects

Common side effects:

  • Nausea and vomiting
  • Headache
  • Insomnia and restlessness
  • Rapid heart rate (tachycardia)
  • Tremor or shakiness
  • Stomach upset or abdominal pain
  • Nervousness or anxiety
  • Dizziness

Serious side effects requiring immediate medical attention:

  • Seizures
  • Severe irregular heart rhythms (arrhythmias)
  • Persistent vomiting
  • Signs of toxicity including confusion, severe tremor, or difficulty breathing
  • Chest pain or severe palpitations

Warnings and precautions

Narrow therapeutic window: Theophylline has a very narrow range between effective and toxic doses, requiring regular blood level monitoring to ensure safety and effectiveness.

Heart conditions: Patients with heart disease, irregular heart rhythms, or high blood pressure should use theophylline with extreme caution as it can worsen these conditions.

Liver disease: Individuals with liver problems may not metabolize theophylline properly, leading to increased risk of toxicity and requiring dose adjustments.

Pregnancy and breastfeeding: Theophylline crosses the placenta and enters breast milk. While it may be used during pregnancy when benefits outweigh risks, careful monitoring is essential.

Age considerations: Elderly patients and young children may be more sensitive to theophylline’s effects and typically require lower doses and more frequent monitoring.

Interactions

Ciprofloxacin and other fluoroquinolone antibiotics: Can significantly increase theophylline levels by inhibiting its metabolism, potentially leading to toxicity.

Phenytoin: May decrease theophylline effectiveness by increasing its breakdown in the liver, requiring dose adjustments.

Cimetidine: This acid-reducing medication can increase theophylline levels by slowing its elimination from the body.

Smoking: Tobacco and marijuana smoking can increase theophylline metabolism, requiring higher doses for effectiveness.

Caffeine: Can increase the risk of side effects such as nervousness, rapid heart rate, and insomnia when combined with theophylline.

Beta-blockers: May counteract theophylline’s bronchodilating effects and should generally be avoided in patients with respiratory conditions.

Erythromycin and clarithromycin: These antibiotics can increase theophylline blood levels by interfering with its metabolism.

Allopurinol: May increase theophylline levels, particularly at high doses, requiring careful monitoring and possible dose reduction.

Check interactions with the GMJ Interaction Checker

Dosage

Theophylline dosing is highly individualized and based on patient weight, age, smoking status, and blood levels. For adults, initial doses typically range from 300-400 mg daily, divided into two or three doses. Sustained-release formulations are often preferred for better compliance and more stable blood levels. Maintenance doses usually range from 400-800 mg daily, but some patients may require up to 900 mg daily. Regular blood level monitoring is essential, with target therapeutic levels typically between 10-20 mcg/mL. Dosage adjustments should always be made gradually and under close medical supervision.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Theophylline." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/theophylline/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Levetiracetam

By
Prof. Giorgi Pkhakadze
02/06/2026

Montelukast

By
Prof. Giorgi Pkhakadze
02/06/2026

Valerian

By
Prof. Giorgi Pkhakadze
02/06/2026

Ivabradine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up